Fiduciary Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$841K Sell
10,748
-24
-0.2% -$1.88K 0.01% 438
2025
Q1
$781K Sell
10,772
-4,182
-28% -$303K 0.01% 444
2024
Q4
$1.11M Buy
14,954
+1,268
+9% +$93.9K 0.01% 341
2024
Q3
$903K Sell
13,686
-5
-0% -$330 0.01% 384
2024
Q2
$1.26M Sell
13,691
-476
-3% -$44K 0.02% 299
2024
Q1
$1.35M Sell
14,167
-225
-2% -$21.5K 0.02% 293
2023
Q4
$1.1M Sell
14,392
-230
-2% -$17.5K 0.02% 318
2023
Q3
$1.01M Buy
14,622
+148
+1% +$10.3K 0.02% 321
2023
Q2
$1.37M Sell
14,474
-133
-0.9% -$12.5K 0.02% 286
2023
Q1
$1.21M Hold
14,607
0.02% 295
2022
Q4
$1.09M Sell
14,607
-3,334
-19% -$249K 0.02% 321
2022
Q3
$1.48M Sell
17,941
-120
-0.7% -$9.92K 0.03% 266
2022
Q2
$1.72M Sell
18,061
-1
-0% -$95 0.04% 256
2022
Q1
$2.13M Buy
18,062
+50
+0.3% +$5.89K 0.04% 244
2021
Q4
$2.33M Buy
18,012
+210
+1% +$27.2K 0.04% 234
2021
Q3
$2.02M Buy
17,802
+307
+2% +$34.7K 0.04% 238
2021
Q2
$1.81M Buy
17,495
+2,814
+19% +$291K 0.04% 258
2021
Q1
$1.23M Buy
14,681
+5
+0% +$418 0.02% 302
2020
Q4
$1.34M Buy
14,676
+1,370
+10% +$125K 0.03% 282
2020
Q3
$1.06M Buy
13,306
+2,613
+24% +$209K 0.03% 283
2020
Q2
$739K Buy
10,693
+4,666
+77% +$322K 0.02% 324
2020
Q1
$379K Sell
6,027
-789
-12% -$49.6K 0.01% 381
2019
Q4
$530K Sell
6,816
-471
-6% -$36.6K 0.01% 371
2019
Q3
$534K Sell
7,287
-57
-0.8% -$4.18K 0.01% 359
2019
Q2
$453K Sell
7,344
-399
-5% -$24.6K 0.01% 364
2019
Q1
$494K Buy
7,743
+69
+0.9% +$4.4K 0.01% 350
2018
Q4
$392K Hold
7,674
0.01% 354
2018
Q3
$445K Buy
7,674
+750
+11% +$43.5K 0.01% 351
2018
Q2
$336K Buy
6,924
+315
+5% +$15.3K 0.01% 382
2018
Q1
$307K Buy
+6,609
New +$307K 0.01% 380
2017
Q3
Sell
-5,082
Closed -$200K 458
2017
Q2
$200K Buy
+5,082
New +$200K 0.01% 436
2016
Q4
Sell
-5,082
Closed -$204K 442
2016
Q3
$204K Buy
+5,082
New +$204K 0.01% 428